Dr. Gust Bardy, president of the Seattle Institute for Cardiac Research and lead investigator of the Home Automated External Defibrillator Trial (HAT), published in the New England Journal of Medicine, will discuss the use of automated external defibrillators, both at home and in public locations, as a strategy to reduce mortality rates among patients who are at higher risk for sudden cardiac death.